MicroRNAs miR-1, miR-133a, miR-133b, miR-208a and miR-208b are dysregulated in Chronic Chagas disease Cardiomyopathy

被引:84
作者
Pinto Ferreira, Ludmila Rodrigues [1 ,2 ,3 ]
Frade, Amanda Farage [1 ,2 ,3 ]
Barros Santos, Ronaldo Honorato [4 ]
Teixeira, Priscila Camillo [1 ,2 ,3 ]
Baron, Monique Andrade [1 ,2 ,3 ]
Navarro, Isabela Cunha [1 ,2 ,3 ]
Benvenuti, Luiz Alberto [5 ]
Fiorelli, Alfredo Inacio [4 ]
Bocchi, Edimar Alcides [4 ]
Stolf, Noedir Antonio [4 ]
Chevillard, Christophe [6 ]
Kalil, Jorge [2 ,3 ]
Cunha-Neto, Edecio [1 ,2 ,3 ]
机构
[1] Univ Sao Paulo, Sch Med, Heart Inst InCor, Immunol Lab, Sao Paulo, Brazil
[2] Univ Sao Paulo, Sch Med, Div Clin Immunol & Allergy, Sao Paulo, Brazil
[3] INCT, Inst Invest Immunol, BR-05403001 Sao Paulo, Brazil
[4] Univ Sao Paulo, Sch Med, Heart Inst InCor, Div Surg, Sao Paulo, Brazil
[5] Univ Sao Paulo, Sch Med, Heart Inst InCor, Div Pathol, Sao Paulo, Brazil
[6] Aix Marseille Univ, Fac Med, INSERM, U906, Marseille, France
基金
巴西圣保罗研究基金会;
关键词
Chagas disease; Trypanosoma cruzi; miRNA; Heart; HEART-FAILURE; CARDIAC-HYPERTROPHY; EXPRESSION; DYSFUNCTION; BIOMARKERS; REGULATOR; CYCLINS;
D O I
10.1016/j.ijcard.2014.05.019
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background/methods: Chagas disease is caused by an intracellular parasite, Trypanosoma cruzi, and it is a leading cause of heart failure in Latin America. The main clinical consequence of the infection is the development of a Chronic Chagas disease Cardiomyopathy (CCC), which is characterized by myocarditis, hypertrophy and fibrosis and affects about 30% of infected patients. CCC has a worse prognosis than other cardiomyopathies, like idiopathic dilated cardiomyopathy (DCM). It is well established that myocardial gene expression patterns are altered in CCC, but the molecular mechanisms underlying these differences are not clear. MicroRNAs are recently discovered regulators of gene expression, and are recognized as important factors in heart development and cardiovascular disorders (CD). We analyzed the expression of nine different miRNAs inmyocardial tissue samples of CCC patients in comparison to DCM patients and samples from heart transplant donors. Using the results of a cDNA microarray database on CCC and DCM myocardium, signaling networks were built and nodal molecules were identified. Results: We observed that five miRNAs were significantly altered in CCC and three in DCM; importantly, three miRNAs were significantly reduced in CCC as compared to DCM. We observed that multiple gene targets of the differentially expressed miRNAs showed a concordant inverse expression in CCC. Significantly, most gene targets and involved networks belong to crucial disease-related signaling pathways. Conclusion: These results suggest that miRNAs may play a major role in the regulation of gene expression in CCC pathogenesis, with potential implication as diagnostic and prognostic tools. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:409 / 417
页数:9
相关论文
共 31 条
[1]   The functions of animal microRNAs [J].
Ambros, V .
NATURE, 2004, 431 (7006) :350-355
[2]   MicroRNAs and developmental timing [J].
Ambros, Victor .
CURRENT OPINION IN GENETICS & DEVELOPMENT, 2011, 21 (04) :511-517
[3]   MicroRNAs: History, Biogenesis, and Their Evolving Role in Animal Development and Disease [J].
Bhaskaran, M. ;
Mohan, M. .
VETERINARY PATHOLOGY, 2014, 51 (04) :759-774
[4]   Cardiomyopathy, adult valve disease and heart failure in South America [J].
Bocchi, E. A. ;
Guimaraes, G. ;
Tarasoutshi, F. ;
Spina, G. ;
Mangini, S. ;
Bacal, F. .
HEART, 2009, 95 (03) :181-189
[5]   Cyclin D in Left Ventricle Hypertrophy [J].
Busk, Peter K. ;
Hinrichsen, Rebecca .
CELL CYCLE, 2003, 2 (02) :91-95
[6]   MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice [J].
Callis, Thomas E. ;
Pandya, Kumar ;
Seok, Hee Young ;
Tang, Ru-Hang ;
Tatsuguchi, Mariko ;
Huang, Zhan-Peng ;
Chen, Jian-Fu ;
Deng, Zhongliang ;
Gunn, Bronwyn ;
Shumate, Janelle ;
Willis, Monte S. ;
Selzman, Craig H. ;
Wang, Da-Zhi .
JOURNAL OF CLINICAL INVESTIGATION, 2009, 119 (09) :2772-2786
[7]   MicroRNA-133 controls cardiac hypertrophy [J].
Care, Alessandra ;
Catalucci, Daniele ;
Felicetti, Federica ;
Bonci, Desiree ;
Addario, Antonio ;
Gallo, Paolo ;
Bang, Marie-Louise ;
Segnalini, Patrizia ;
Gu, Yusu ;
Dalton, Nancy D. ;
Elia, Leonardo ;
Latronico, Michael V. G. ;
Hoydal, Morten ;
Autore, Camillo ;
Russo, Matteo A. ;
Dorn, Gerald W., II ;
Ellingsen, Oyvind ;
Ruiz-Lozano, Pilar ;
Peterson, Kirk L. ;
Croce, Carlo M. ;
Peschle, Cesare ;
Condorelli, Gianluigi .
NATURE MEDICINE, 2007, 13 (05) :613-618
[8]   Role of microRNAs in plant and animal development [J].
Carrington, JC ;
Ambros, V .
SCIENCE, 2003, 301 (5631) :336-338
[9]   Emerging and under-recognized Chagas cardiomyopathy in non-endemic countries [J].
Cortez, Joana ;
Providencia, Rui ;
Ramos, Evelise ;
Valente, Cristina ;
Seixas, Jorge ;
Meruje, Manuela ;
Leitao-Marques, Antonio ;
Vieira, Antonio .
WORLD JOURNAL OF CARDIOLOGY, 2012, 4 (07) :234-239
[10]   Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy [J].
Cunha-Neto, E ;
Dzao, VJ ;
Allen, PD ;
Stamatiou, D ;
Benvenutti, L ;
Higuchi, ML ;
Koyama, NS ;
Silva, JS ;
Kalil, J ;
Liew, CC .
AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (02) :305-313